Midregional pro-atrial natriuretic peptide: A novel marker of myocardial fibrosis in patients with hypertrophic cardiomyopathy

International Journal of Cardiovascular Imaging

Volumn 27, Issue 4, 2011, Pages 547-556

  Elmas, Elif ^a   Doesch, Christina ^a   Fluechter, Stephan ^a   Freundt, Miriam ^a   Weiss, Christel ^b   Lang, Siegfried ^a   Kälsch, Thorsten ^a   Haghi, Dariush ^a   Papassotiriou, Jana ^c   Kunde, Jan ^c   Schoenberg, Stefan O ^b   Borggrefe, Martin ^a   Papavassiliu, Theano ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c BRAHMS AG   (Germany)

Author keywords

Biochemical markers; Fibrosis; Hypertrophic cardiomyopathy; MR proANP

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CARBOXY TERMINAL PROENDOTHELIN 1; CARBOXY TERMINAL PROVASOPRESSIN; GADOLINIUM PENTETATE; GELATINASE B; INTERLEUKIN 8; MIDREGIONAL PROADRENOMEDULLIN; MIDREGIONAL PROATRIAL NATRIURETIC PEPTIDE; PREPROENDOTHELIN 1; PROADRENOMEDULLIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG; VASOPRESSIN;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HEART MUSCLE FIBROSIS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ADRENOMEDULLIN; ADULT; AGED; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CARDIOMYOPATHY, HYPERTROPHIC; CONTRAST MEDIA; ENDOTHELIN-1; FEMALE; FIBROSIS; GADOLINIUM DTPA; GERMANY; GLYCOPEPTIDES; HUMANS; INTERLEUKIN-8; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MYOCARDIUM; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; ROC CURVE; STROKE VOLUME; TISSUE INHIBITOR OF METALLOPROTEINASE-1; VENTRICULAR FUNCTION, LEFT;

EID: 79958107581     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-010-9704-2     Document Type: Article

References (52)

1. AJ Marian R Roberts 1995 Recent advances in the molecular genetics of hypertrophic cardiomyopathy Circulation 92 5 1336 1347 7648684 1:CAS:528:DyaK2MXosF2mtro%3D
2. H Niimura LL Bachinski S Sangwatanaroj, et al. 1998 Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy N Engl J Med 338 18 1248 1257 9562578 10.1056/NEJM199804303381802 1:CAS:528:DyaK1cXivF2qtrY%3D (Pubitemid 28216578)
3. K Schwartz L Carrier P Guicheney, et al. 1995 Molecular basis of familial cardiomyopathies Circulation 91 2 532 540 7805259 1:CAS:528:DyaK2MXjvVKqsbw%3D
4. BJ Maron P Spirito 1998 Implications of left ventricular remodeling in hypertrophic cardiomyopathy Am J Cardiol 81 11 1339 1344 9631972 10.1016/S0002-9149(98)00164-7 1:STN:280:DyaK1c3ptlOgsQ%3D%3D (Pubitemid 28268673)
5. BJ Maron 2002 Hypertrophic cardiomyopathy: a systematic review JAMA 287 10 1308 1320 11886323 10.1001/jama.287.10.1308 (Pubitemid 34250486)
6. AM Varnava PM Elliott S Sharma, et al. 2000 Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease Heart 84 5 476 482 11040002 10.1136/heart.84.5.476 1:STN:280:DC%2BD3cvptVektQ%3D%3D
7. PB Bottini AA Carr LM Prisant, et al. 1995 Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient Am J Hypertens 8 3 221 228 7794570 10.1016/0895-7061(94)00178-E 1:STN:280:DyaK2MzhsVyhsw%3D%3D
8. CH Lorenz ES Walker VL Morgan, et al. 1999 Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging J Cardiovasc Magn Reson 1 1 7 21 11550343 10.3109/ 10976649909080829 1:STN:280:DC%2BD3MrgtFahsA%3D%3D
9. L Choudhury H Mahrholdt A Wagner, et al. 2002 Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy J Am Coll Cardiol 40 12 2156 2164 12505229 10.1016/S0735-1097(02)02602-5 (Pubitemid 36005903)
10. RJ Kim RM Judd 2003 Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death? J Am Coll Cardiol 41 9 1568 1572 12742299 10.1016/S0735-1097(03)00190-6 (Pubitemid 36543377)
11. JC Moon E Reed MN Sheppard, et al. 2004 The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy J Am Coll Cardiol 43 12 2260 2264 15193690 10.1016/j.jacc.2004. 03.035 (Pubitemid 38757595)
12. T Germans AC van Rossum 2008 The use of cardiac magnetic resonance imaging to determine the aetiology of left ventricular disease and cardiomyopathy Heart 94 4 510 518 18347381 10.1136/hrt.2007.122770 (Pubitemid 351441415)
13. T Papavassiliu P Schnabel M Schroder, et al. 2005 CMR scarring in a patient with hypertrophic cardiomyopathy correlates well with histological findings of fibrosis Eur Heart J 26 22 2395 16263729 10.1093/eurheartj/ehi518 (Pubitemid 41552968)
14. DH Kwon RM Setser ZB Popovic, et al. 2008 Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study Int J Cardiovasc Imaging 24 6 617 625 18204915 10.1007/s10554-008-9292-6
15. R Lombardi S Betocchi MA Losi, et al. 2003 Myocardial collagen turnover in hypertrophic cardiomyopathy Circulation 108 12 1455 1460 12952838 10.1161/01.CIR.0000090687.97972.10 1:CAS:528:DC%2BD3sXntlartbs%3D (Pubitemid 37176451)
16. G Derchi P Bellone F Chiarella, et al. 1992 Plasma levels of atrial natriuretic peptide in hypertrophic cardiomyopathy Am J Cardiol 70 18 1502 1504 1442630 10.1016/0002-9149(92)90311-L 1:STN:280:DyaK3s%2FntFOktQ%3D%3D
17. GJ Fahy CJ McCreery F O'Sullivan, et al. 1996 Plasma atrial natriuretic peptide is elevated in patients with hypertrophic cardiomyopathy Int J Cardiol 55 2 149 155 8842784 10.1016/0167-5273(96)02662-9 1:STN:280:DyaK28vktVCksQ%3D%3D (Pubitemid 26246911)
18. K Ogino K Ogura T Kinugawa, et al. 2004 Neurohumoral profiles in patients with hypertrophic cardiomyopathy: differences to hypertensive left ventricular hypertrophy Circ J 68 5 444 450 15118286 10.1253/circj.68.444 (Pubitemid 38657533)
19. K Hasegawa H Fujiwara M Koshiji, et al. 1996 Endothelin-1 and its receptor in hypertrophic cardiomyopathy Hypertension 27 2 259 264 8567049 1:STN:280:DyaK287msFagsQ%3D%3D (Pubitemid 26045924)
20. M Hamada Y Shigematsu H Kawakami, et al. 1998 Increased plasma levels of adrenomedullin in patients with hypertrophic cardiomyopathy: its relation to endothelin-I, natriuretic peptides and noradrenaline Clin Sci (Lond) 94 1 21 28 1:STN:280:DyaK1c7ms1Olsw%3D%3D (Pubitemid 28029804)
21. T Seidler C Pemberton T Yandle, et al. 1999 The amino terminal regions of proBNP and proANP oligomerise through leucine zipper-like coiled-coil motifs Biochem Biophys Res Commun 255 2 495 501 10049737 10.1006/bbrc.1999.0225 1:CAS:528:DyaK1MXhsVShtb4%3D (Pubitemid 29292288)
22. JP Hinson S Kapas DM Smith 2000 Adrenomedullin, a multifunctional regulatory peptide Endocr Rev 21 2 138 167 10782362 10.1210/er.21.2.138 1:CAS:528:DC%2BD3cXivFGitr8%3D (Pubitemid 32275593)
23. GL Robertson EA Mahr S Athar, et al. 1973 Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma J Clin Invest 52 9 2340 2352 4727463 10.1172/JCI107423 1:CAS:528:DyaE3sXltFaru74%3D
24. J Struck NG Morgenthaler A Bergmann 2005 Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients Peptides 26 12 2500 2504 15922490 10.1016/j.peptides.2005.04.019 1:CAS:528:DC%2BD2MXht1Ggtr3K (Pubitemid 41676723)
25. NG Morgenthaler J Struck B Thomas, et al. 2004 Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma Clin Chem 50 1 234 236 14709661 10.1373/clinchem.2003.021204 1:CAS:528: DC%2BD2cXovFWmug%3D%3D (Pubitemid 38125732)
26. NG Morgenthaler J Struck C Alonso, et al. 2005 Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay Clin Chem 51 10 1823 1829 16099941 10.1373/clinchem.2005.051110 1:CAS:528:DC%2BD2MXhtVGmtbrO (Pubitemid 41368172)
27. NG Morgenthaler J Struck C Alonso, et al. 2006 Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin Clin Chem 52 1 112 119 16269513 10.1373/clinchem.2005.060038 1:CAS:528: DC%2BD28Xitlyguw%3D%3D (Pubitemid 43032474)
28. J Papassotiriou NG Morgenthaler J Struck, et al. 2006 Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma Clin Chem 52 6 1144 1151 16627560 10.1373/clinchem.2005.065581 1:CAS:528:DC%2BD28XltlSrurw%3D (Pubitemid 43794428)
29. E Elmas S Lang C Erik Dempfle, et al. 2007 High plasma levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and interleukin-8 (IL-8) characterize patients prone to ventricular fibrillation complicating myocardial infarction Clin Chem Lab Med 45 10 1360 1365 17727318 10.1515/CCLM.2007.286 1:CAS:528:DC%2BD2sXhtlWmsLfF (Pubitemid 47557078)
30. OP Simonetti RJ Kim DS Fieno, et al. 2001 An improved MR imaging technique for the visualization of myocardial infarction Radiology 218 1 215 223 11152805 1:STN:280:DC%2BD3MzitFCntg%3D%3D (Pubitemid 32151298)
31. B Sievers S Kirchberg M Addo, et al. 2004 Assessment of left atrial volumes in sinus rhythm and atrial fibrillation using the biplane area-length method and cardiovascular magnetic resonance imaging with TrueFISP J Cardiovasc Magn Reson 6 4 855 863 15646889 10.1081/JCMR-200036170 (Pubitemid 40041290)
32. JM Bland DG Altman 1986 Statistical methods for assessing agreement between two methods of clinical measurement Lancet 1 8476 307 310 2868172 10.1016/S0140-6736(86)90837-8 1:STN:280:DyaL287hslWqsQ%3D%3D (Pubitemid 16134762)
33. JC Moon J Mogensen PM Elliott, et al. 2005 Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I Heart 91 8 1036 1040 16020591 10.1136/hrt.2004.041384 1:CAS:528:DC%2BD2MXps1Cku7c%3D (Pubitemid 41060010)
34. K Teraoka M Hirano H Ookubo, et al. 2004 Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy Magn Reson Imaging 22 2 155 161 15010107 10.1016/j.mri.2003.08.009 (Pubitemid 38326634)
35. A Rudolph H Abdel-Aty S Bohl, et al. 2009 Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling J Am Coll Cardiol 53 3 284 291 19147047 10.1016/j.jacc.2008.08.064
36. AS Adabag BJ Maron E Appelbaum, et al. 2008 Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance J Am Coll Cardiol 51 14 1369 1374 18387438 10.1016/j.jacc.2007.11.071 (Pubitemid 351443083)
37. V Roldan F Marin JR Gimeno, et al. 2008 Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy Am Heart J 156 1 85 91 18585501 10.1016/j.ahj.2008.01.035 1:CAS:528:DC%2BD1cXnvVGks7g%3D (Pubitemid 351862294)
38. G Takemura H Fujiwara M Mukoyama, et al. 1991 Expression and distribution of atrial natriuretic peptide in human hypertrophic ventricle of hypertensive hearts and hearts with hypertrophic cardiomyopathy Circulation 83 1 181 190 1824622 1:STN:280:DyaK3M%2FosV2msA%3D%3D
39. J McMurray MA Pfeffer 2002 New therapeutic options in congestive heart failure: part II Circulation 105 18 2223 2228 11994259 10.1161/01.CIR. 0000014771.38666.22 (Pubitemid 34517169)
40. E Elmas M Brueckmann S Lang, et al. 2008 Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease Int J Cardiol 128 2 244 249 17673312 10.1016/j.ijcard.2007.04.113 (Pubitemid 352033584)
41. S von Haehling EA Jankowska NG Morgenthaler, et al. 2007 Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure J Am Coll Cardiol 50 20 1973 1980 10.1016/j.jacc.2007.08.012 (Pubitemid 350046336)
42. T Nishikimi F Yoshihara Y Mori, et al. 2003 Cardioprotective effect of adrenomedullin in heart failure Hypertens Res 26 Suppl S121 S127 12630822 10.1291/hypres.26.S121 1:CAS:528:DC%2BD3sXisVKhsrg%3D (Pubitemid 36372327)
43. E Elmas S Lang CE Dempfle, et al. 2008 Diagnostic performance of mid-regional pro-adrenomedullin as an analyte for the exclusion of left ventricular dysfunction Int J Cardiol 128 1 107 111 17698224 10.1016/j.ijcard.2007.04.117 (Pubitemid 351905763)
44. T Suzuki H Hoshi Y Mitsui 1990 Endothelin stimulates hypertrophy and contractility of neonatal rat cardiac myocytes in a serum-free medium FEBS Lett 268 1 149 151 2200708 10.1016/0014-5793(90)80995-U 1:CAS:528:DyaK3cXltV2qu78%3D (Pubitemid 20233853)
45. T Neunteufl R Berger R Pacher 2002 Endothelin receptor antagonists in cardiology clinical trials Expert Opin Investig Drugs 11 3 431 443 11866670 10.1517/13543784.11.3.431 1:CAS:528:DC%2BD38XitFCmurc%3D (Pubitemid 34213395)
46. LE Spieker G Noll FT Ruschitzka, et al. 2001 Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future? J Am Coll Cardiol 37 6 1493 1505 11345356 10.1016/S0735-1097(01)01210-4 1:CAS:528:DC%2BD3MXjvVarsLw%3D (Pubitemid 32385980)
47. S Sakai T Miyauchi M Kobayashi, et al. 1996 Inhibition of myocardial endothelin pathway improves long-term survival in heart failure Nature 384 6607 353 355 8934519 10.1038/384353a0 1:CAS:528:DyaK28Xnt1aisLk%3D (Pubitemid 26408515)
48. M Behnes J Papassotiriou T Walter, et al. 2008 Long-term prognostic value of mid-regional pro-adrenomedullin and C-terminal pro-endothelin-1 in patients with acute myocardial infarction Clin Chem Lab Med 46 2 204 211 18076360 10.1515/CCLM.2008.040 1:CAS:528:DC%2BD1cXjtFChur4%3D
49. C Serradeil-Le Gal J Wagnon G Valette, et al. 2002 Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands Prog Brain Res 139 197 210 12436936 10.1016/S0079-6123(02) 39017-4 1:CAS:528:DC%2BD38XovFGrs70%3D (Pubitemid 35460890)
50. SQ Khan OS Dhillon RJ O'Brien, et al. 2007 C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester acute myocardial infarction peptide (LAMP) study Circulation 115 16 2103 2110 17420344 10.1161/CIRCULATIONAHA.106.685503 1:CAS:528: DC%2BD2sXktlSnu7w%3D (Pubitemid 46659061)
51. A Esposito F De Cobelli G Perseghin, et al. 2009 Impaired left ventricular energy metabolism in patients with Hypertrophic Cardiomyopathy is related to the extension of fibrosis at gadolinium delayed enhanced MR imaging Heart 95 3 228 233 18708417 10.1136/hrt.2008.142562 1:STN:280: DC%2BD1M%2FntVCnsQ%3D%3D
52. JC Moon WJ McKenna JA McCrohon, et al. 2003 Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance J Am Coll Cardiol 41 9 1561 1567 12742298 10.1016/S0735-1097(03)00189-X (Pubitemid 36543376)